Subsequently, we showed that STAT4 overexpression could significantly inhibit proliferation and migration, promote apoptosis, and reduce the lactate content of DLBCL cells, suggesting that targeting STAT4 may effectively reduce lactate in the tumor microenvironment and exert an antitumor therapeutic effect. This evidence concerns the gene STAT4 and neoplasm.